59 related articles for article (PubMed ID: 24511027)
1. Tumor marker score for prognostication of early-stage squamous cell cervical cancer.
Hellberg D; Tot T
Anticancer Res; 2014 Feb; 34(2):887-92. PubMed ID: 24511027
[TBL] [Abstract][Full Text] [Related]
2. Pitfalls in immunohistochemical validation of tumor marker expression--exemplified in invasive cancer of the uterine cervix.
Hellberg D; Tot T; Stendahl U
Gynecol Oncol; 2009 Jan; 112(1):235-40. PubMed ID: 18976801
[TBL] [Abstract][Full Text] [Related]
3. LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix.
Hedman H; Lindström AK; Tot T; Stendahl U; Henriksson R; Hellberg D
Acta Oncol; 2010 Aug; 49(6):812-5. PubMed ID: 20553099
[TBL] [Abstract][Full Text] [Related]
4. Discrepancies in expression and prognostic value of tumor markers in adenocarcinoma and squamous cell carcinoma in cervical cancer.
Lindström AK; Tot T; Stendahl U; Syrjänen S; Syrjänen K; Hellberg D
Anticancer Res; 2009 Jul; 29(7):2577-8. PubMed ID: 19596931
[TBL] [Abstract][Full Text] [Related]
5. Expression of LRIG1 and LRIG3 correlates with human papillomavirus status and patient survival in cervical adenocarcinoma.
Muller S; Lindquist D; Kanter L; Flores-Staino C; Henriksson R; Hedman H; Andersson S
Int J Oncol; 2013 Jan; 42(1):247-52. PubMed ID: 23165628
[TBL] [Abstract][Full Text] [Related]
6. Differences in expression of tumor markers between pre- and postmenopausal women with invasive cervical cancer.
Hellberg D; Tot T; Stendahl U
Anticancer Res; 2008; 28(3B):1793-5. PubMed ID: 18630462
[TBL] [Abstract][Full Text] [Related]
7. [Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues].
Liu R; Pu DM; Cheng YX; Yin L
Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1326-9. PubMed ID: 17727777
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor (VDR) expression is not a prognostic factor in cervical cancer.
Friedrich M; Meyberg R; Axt-Fliedner R; Villena-Heinsen C; Tilgen W; Schmidt W; Reichrath J
Anticancer Res; 2002; 22(1A):299-304. PubMed ID: 12017307
[TBL] [Abstract][Full Text] [Related]
9. Relationship between decreased expression of squamous cell carcinoma antigen 2 and E-cadherin in primary cervical cancer lesions and lymph node metastasis.
Murakami A; Nakagawa T; Fukushima C; Torii M; Sueoka K; Nawata S; Takeda O; Ishikawa H; Sugino N
Oncol Rep; 2008 Jan; 19(1):99-104. PubMed ID: 18097581
[TBL] [Abstract][Full Text] [Related]
10. [Expression of P53, COX2 and CD44V6 in early-stage squamous carcinoma of cervix with lymph vascular space invasion positive and negative and its relationship with prognosis].
Zhang R; Song Y; Gao WJ; Zhang X; Zuo J; Lei CZ; Wang Y
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(47):3341-5. PubMed ID: 20193563
[TBL] [Abstract][Full Text] [Related]
11. Tumor biomarkers in cervical cancer: focus on Ki-67 proliferation factor and E-cadherin expression.
Ancuţa E; Ancuţa C; Cozma LG; Iordache C; Anghelache-Lupaşcu I; Anton E; Carasevici E; Chirieac R
Rom J Morphol Embryol; 2009; 50(3):413-8. PubMed ID: 19690767
[TBL] [Abstract][Full Text] [Related]
12. Expression of iNOS--a favourable prognostic marker for early-stage carcinoma of the uterine cervix.
Eggen T; Sager G; Arnes M; Pettersen I; Ørbo A
Anticancer Res; 2011 Jun; 31(6):2319-25. PubMed ID: 21737658
[TBL] [Abstract][Full Text] [Related]
13. [Assessment tumor markers by immunohistochemistry (Ki67, p53 and Bcl-2) on a cohort of patients with cervical cancer in various stages of evolution].
Stoenescu TM; Ivan LD; Stoenescu N; Azoicăi D
Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):485-92. PubMed ID: 21870745
[TBL] [Abstract][Full Text] [Related]
14. Significant effects of lymph and blood vascular invasion on the prognosis of early-stage cervical squamous cell carcinoma.
Zhang Y; Yan M; He J; Sun J; Sun X
J Obstet Gynaecol Res; 2010 Oct; 36(5):1015-22. PubMed ID: 20846259
[TBL] [Abstract][Full Text] [Related]
15. Expression of BDNF, TrkB, and p53 in early-stage squamous cell carcinoma of the uterine cervix.
Moon A; Won KY; Lee JY; Kang I; Lee SK; Lee J
Pathology; 2011 Aug; 43(5):453-8. PubMed ID: 21670725
[TBL] [Abstract][Full Text] [Related]
16. Expression of p53, Ki-67, and CD31 in the vaginal margins of radical hysterectomy in patients with stage IB carcinoma of the cervix.
Silva-Filho AL; Traiman P; Triginelli SA; Reis FM; Pedrosa MS; Miranda D; Abreu ES; Macarenco RS; Cunha-Melo JR
Gynecol Oncol; 2004 Dec; 95(3):646-54. PubMed ID: 15581977
[TBL] [Abstract][Full Text] [Related]
17. S100A2 expression as a predictive marker for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral cavity.
Suzuki F; Oridate N; Homma A; Nakamaru Y; Nagahashi T; Yagi K; Yamaguchi S; Furuta Y; Fukuda S
Oncol Rep; 2005 Dec; 14(6):1493-8. PubMed ID: 16273244
[TBL] [Abstract][Full Text] [Related]
18. [Immunohistochemical study of the predictive value of oncoproteins p53, HER-2 and c-myc during radiotherapy for squamous cell carcinoma of the cervix].
Gasparian NA; Pozharisskiĭ KM; Zharinov GM; Vinokurov VL; Kuznetsova ME; Neklasova NIu
Vopr Onkol; 2007; 53(4):439-44. PubMed ID: 17969407
[TBL] [Abstract][Full Text] [Related]
19. Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression.
Sotiropoulou N; Bravou V; Kounelis S; Damaskou V; Papaspirou E; Papadaki H
Pathology; 2010 Dec; 42(7):629-36. PubMed ID: 21080871
[TBL] [Abstract][Full Text] [Related]
20. [Expression of ETV5 and MMP-7 in early stage cervical squamous cell carcinoma and its role in lymphatic metastasis].
Wu SH; Zhang J; Li Y; Li JM
Ai Zheng; 2006 Mar; 25(3):315-9. PubMed ID: 16536985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
